8-K - Oramed Pharmaceuticals Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. On January 7, 2026, Oramed Pharmaceuticals Inc. (the “Company”) issued a press release announcing it has received an $18 million payment from Scil

Other Event

$10.5M

9.01

Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release dated January 7, 2026. 104 Cover Page Interactive Data File (embedded

Exhibits Only

Source Document

Exhibits (2)

8-K

CURRENT REPORT

99.1

PRESS RELEASE DATED JANUARY 7, 2026